ISSVA 2020 in Vancouver 12-15 may
- Details
- Created on 31 January 2019
The 23rd ISSVA meeting will be held in Vancouver 12-15 may 2020.
NSVA 7-8 october 2019 in Helsinki - program and registration
- Details
- Created on 31 January 2019
The 2019 NSVA meeting will take place 7-8 of october at Gustavelund at the shores of lake Tuusula just outside of Helsinki. Please see the attched file for program and registration details. There will be a general assembly monday the 7th at 16:00.
PROGRAM
Monday October 7, 2019
09:30 Registration, refreshments, coffee and tea
Session 1 Classification of vascular anomalies and update of VASCERN and VASCA
10:00 Welcome
Update on the ISSVA Classification (2018) of Vascular Anomalies
Dr Päivi Salminen, Helsinki University Hospital
10:10 Update on VASCERN and VASCA activities
Prof Miikka Vikkula, de Duve Institute, UCLouvain, Brussels
Session 2 Arteriovenous malformations
Chair Dr Pia Vuola, Helsinki University Hospital
10:30 Cervico-facial AVMs – what changes in our treatment approach in 2019
Dr Annouk Bisdorff, Prof Benoit Faucon, Lariboisiere Hospital, Paris
11:30 Helsinki approach to AVMs
Dr Kimmo Lappalainen, Helsinki University Hospital
12:30 Lunch
13:30 Multimodal treatment of AVMs
Prof Laurence Boon, Cliniques Universitaires Saint-Luc, Brussels
14:30 Do you recognize CM-AVM?
Prof Miikka Vikkula, de Duve Institute, UCLouvain, Brussels
14:45 Refreshments, coffee and tea
Session 3 Clinical cases, tips and tricks
Chair Dr Kristiina Kyrklund, Helsinki University Hospital
15:00 Facial AVM
Nader Ghaffarpour, Karolinska University Hospital
Large AVM of the scalp and AVM of the mandible
Alexandros Rentzos, Sahlgrenska University Hospital
Operative treatment of two AVMs in lower extremity
Erkki Tukiainen, Helsinki University Hospital
Strange renal AVM and complication to embolization
Susanne Frevert, Rigshospitalet, Copenhagen
Venolymphatic malformation
Viveque Egsgaard, Odense
16:15 General Assembly
Tuesday October 8, 2019
Session 4 Clinical Pharmacology
Chair Dr Päivi Salminen, Helsinki University Hospital
09:00 Translational research and personalized medicine
Caroline Heckman, PhD, FIMM Institute for Molecular Medicine
10:00 Pharmacogenetics
Prof Mikko Niemi, Clinical Pharmacology, University of Helsinki
11:00 Refreshments, coffee and tea
11:30 Safety profile and side effects of sirolimus
Prof Laurence Boon, Cliniques Universitaires Saint-Luc, Brussels
12:00 Long-term experience of bleomycin in oncology
Dr Rita Janes, Helsinki University Hospital
12:30 Lunch
Session 5 Clinical cases, tips and tricks, controversies and complications
Chair Dr Kristiina Kyrklund, Helsinki University Hospital
13:30 Unintended positive effect of medical treatment in a severe venous malformation of the pelvis. Large benign vascular tumor of the pelvis.
Rune Anderssen, Oslo University Hospital
Embolization of suspected RICH
Alexandros Rentzos, Sahlgrenska University Hospital
Kaposiform hemangioendothelioma resistant to sirolimus
Hanna Hyvönen, Helsinki University Hospital
14:30 Differential diagnoses of vascular anomalies
Prof Laurence Boon, Cliniques Universitaires Saint-Luc, Brussels
15:00 Clinical cases, tips and tricks
Central conducting lymphatic anomalies
Pär Gerwins, Uppsala University Hospital
Atypical KTS
Pål Bergan, Oslo University Hospital
Extensive venous malformation of the head and neck, treatment recommendations and options?
Laura Mäkinen Helsinki University Hospital
15:45 Closing
